Patents by Inventor Mark R. Robinson
Mark R. Robinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Method and apparatus for non-invasive blood analyte measurement with fluid compartment equilibration
Patent number: 6718189Abstract: A method and apparatus for non-invasively measuring the concentration of an analyte, particularly blood analyte in blood. The method utilizes spectrographic techniques in conjunction with means for equilibrating the concentration of the analyte between the vascular system fluid compartment of the test area and the other tissue fluid compartment. An improved optical interface between a sensor probe and a skin surface or tissue surface of the body containing the blood to be analyzed. Multiple readings during the equilibration period are taken and utilized to show the direction and rate of charge of concentration of the analyte in the blood which is useful in optimizing therapeutic response to the collected data.Type: GrantFiled: May 24, 2001Date of Patent: April 6, 2004Assignees: Rio Grande Medical Technologies, Inc., University of New MexicoInventors: Mark Rohrscheib, Craig Gardner, Mark R. Robinson -
Publication number: 20040029103Abstract: The present invention allows detection of specific cell types based on chemical and functional characteristics of the cells. The invention can discriminate even between cells that are very similar; for example, the invention can discriminate between fetal and maternal red blood cells. The invention can also selectively alter certain cells; for example, by lysing cells of one type while leaving cells of another type unaltered. The invention has numerous applications. For example, the invention allows separation of fetal cells from maternal cells in maternal blood, allowing for fetal genetic screening without many of the drawbacks of current fetal cell acquisition techniques.Type: ApplicationFiled: August 7, 2003Publication date: February 12, 2004Inventors: Mark R. Robinson, Keith Hutchinson, Shonn P. Hendee, Russell E. Abbink
-
Patent number: 6542762Abstract: Methods and apparatus for, preferably, determining noninvasively and in vivo pH in a human. The non-invasive method includes the steps of: generating light at three or more different wavelengths in the range of 1000 nm to 2500 nm; irradiating blood containing tissue; measuring the intensities of the wavelengths emerging from the blood containing tissue to obtain a set of at least three spectral intensities v. wavelengths; and determining the unknown values of pH. The determination of pH is made by using measured intensities at wavelengths that exhibit change in absorbance due to histidine titration. Histidine absorbance changes are due to titration by hydrogen ions. The determination of the unknown pH values is performed by at least one multivariate algorithm using two or more variables and at least one calibration model. The determined pH values are within the physiological ranges observed in blood containing tissue.Type: GrantFiled: June 5, 2000Date of Patent: April 1, 2003Inventors: Mary K. Alam, Mark R. Robinson
-
Method and apparatus for non-invasive blood analyte measurement with fluid compartment equilibration
Publication number: 20020035341Abstract: A method and apparatus for non-invasively measuring the concentration of an analyte, particularly blood analyte in blood. The method utilizes spectrographic techniques in conjunction with means for equilibrating the concentration of the analyte between the vascular system fluid compartment of the test area and the other tissue fluid compartment. An improved optical interface between a sensor probe and a skin surface or tissue surface of the body containing the blood to be analyzed. Multiple readings during the equilibration period are taken and utilized to show the direction and rate of charge of concentration of the analyte in the blood which is useful in optimizing therapeutic response to the collected data.Type: ApplicationFiled: May 24, 2001Publication date: March 21, 2002Applicant: Rio Grande Medical Technologies, Inc.Inventors: Mark Rohrscheib, Craig Gardner, Mark R. Robinson -
Patent number: 6278889Abstract: An improved method and apparatus for determining noninvasively and in vivo one or more unknown values of a known characteristic, particularly the concentration of an analyte in human tissue.Type: GrantFiled: September 30, 1999Date of Patent: August 21, 2001Inventor: Mark R. Robinson
-
Method and apparatus for non-invasive blood analyte measurement with fluid compartment equilibration
Patent number: 6240306Abstract: A method and apparatus for non-invasively measuring the concentration of an analyte, particularly blood analyte in blood. The method utilizes spectrographic techniques in conjunction with equilibrating the concentration of the analyte between the vascular system fluid compartment of the test area and the other tissue fluid compartment. An improved optical interface between a sensor probe and a skin surface or tissue surface of the body containing the blood to be analyzed. Multiple readings during the equilibration period are taken and utilized to show the direction and rate of charge of concentration of the analyte in the blood which is useful in optimizing therapeutic response to the collected data.Type: GrantFiled: June 30, 1999Date of Patent: May 29, 2001Assignees: Rio Grande Medical Technologies, Inc., University of New MexicoInventors: Mark Rohrscheib, Craig Gardner, Mark R. Robinson -
Patent number: 6073037Abstract: Methods and apparatus for, preferably, determining noninvasively and in vivo pH in a human. The non-invasive method includes the steps of: generating light at three or more different wavelengths in the range of 1000 nm to 2500 nm; irradiating blood containing tissue; measuring the intensities of the wavelengths emerging from the blood containing tissue to obtain a set of at least three spectral intensities v. wavelengths; and determining the unknown values of pH. The determination of pH is made by using measured intensities at wavelengths that exhibit change in absorbance due to histidine titration. Histidine absorbance changes are due to titration by hydrogen ions. The determination of the unknown pH values is performed by at least one multivariate algorithm using two or more variables and at least one calibration model. The determined pH values are within the physiological ranges observed in blood containing tissue.Type: GrantFiled: August 10, 1998Date of Patent: June 6, 2000Assignees: Sandia Corporation, Rio Grande Medical Technologies, Inc.Inventors: Mary K. Alam, Mark R. Robinson
-
Patent number: 6061581Abstract: Methods for determining invasively and in vivo pH in a human. The invasive method includes the steps of: generating light at three or more different wavelengths in the range of 1000 nm to 2500 nm; irradiating blood; measuring the intensities of the wavelengths emerging from the blood to obtain a set of at least three spectral intensities v. wavelengths; and determining the unknown values of pH. The determination of pH is made by using measured intensities at wavelengths that exhibit change in absorbance due to histidine titration. Histidine absorbance changes are due to titration by hydrogen ions. The determination of the unknown pH values is performed by at least one multivariate algorithm using two or more variables and at least one calibration model. The determined pH values are within the physiological ranges observed in blood containing tissue.Type: GrantFiled: August 10, 1998Date of Patent: May 9, 2000Inventors: Mary K. Alam, Mark R. Robinson
-
Patent number: 5857462Abstract: Methods and apparatus for determining in a biological material one or more unknown values of at least one known characteristic (e.g. the concentration of an analyte such as glucose in blood or the concentration of one or more blood gas parameters) with a model based on a set of samples with known values of the known characteristics and a multivariate algorithm using several wavelength subsets. The method includes selecting multiple wavelength subsets, from the electromagnetic spectral region appropriate for determining the known characteristic, for use by an algorithm wherein the selection of wavelength subsets improves the model's fitness of the determination for the unknown values of the known characteristic. The selection process utilizes multivariate search methods that select both predictive and synergistic wavelengths within the range of wavelengths utilized. The fitness of the wavelength subsets is determined by the fitness function F=f (cost, performance).Type: GrantFiled: July 24, 1995Date of Patent: January 12, 1999Assignee: Sandia CorporationInventors: Edward V. Thomas, Mark R. Robinson, David M. Haaland
-
Patent number: 5830132Abstract: An improved method and apparatus for determining noninvasively and in vivo one or more unknown values of a known characteristic, particularly the concentration of an analyte in human tissue.Type: GrantFiled: February 3, 1997Date of Patent: November 3, 1998Inventor: Mark R. Robinson
-
Patent number: 5792050Abstract: Methods and apparatus for, preferably, determining noninvasively and in vitro pH in a human. The non-invasive method includes the steps of: generating light at three or more different wavelengths in the range of 1000 nm to 2500 nm; irradiating blood containing tissue; measuring the intensities of the wavelengths emerging from the blood containing tissue to obtain a set of at least three spectral intensities v. wavelengths; and determining the unknown values of pH. The determination of pH is made by using measured intensities at wavelengths that exhibit change in absorbance due to histidine titration. Histidine absorbance changes are due to titration by hydrogen ions. The determination of the unknown pH values is performed by at least one multivariate algorithm using two or more variables and at least one calibration model. The determined pH values are within the physiological ranges observed in blood containing tissue.Type: GrantFiled: March 14, 1996Date of Patent: August 11, 1998Inventors: Mary K. Alam, Mark R. Robinson
-
Patent number: 5636633Abstract: An improved apparatus for diffuse reflectance spectroscopy having a specular control device. The specular control device has at least a first surface divided into an even-numbered plurality of reflecting sections and open or transmitting sections. The number of reflecting sections is equal to the number of open sections. Each reflecting section is situated between a pair of open sections and opposite to another reflecting section. Similarly, each open section is situated between a pair of reflecting sections and is opposite to another open section. In one preferred embodiment, the total surface area of the reflecting sections is equal to the total surface area of the open sections. In another embodiment, the total surface area of the reflecting sections is unequal to the total surface area of the open sections.Type: GrantFiled: August 9, 1995Date of Patent: June 10, 1997Assignee: Rio Grande Medical Technologies, Inc.Inventors: Robert G. Messerschmidt, Mark R. Robinson
-
Patent number: 5630413Abstract: This invention relates to methods and apparatus for, preferably, determining non-invasively and in vivo at least two of the five blood gas parameters (i.e., pH, [HCO.sub.3.sup.- ], PCO.sub.2, PO.sub.2, and O.sub.2 sat.) in a human.Type: GrantFiled: August 12, 1994Date of Patent: May 20, 1997Assignee: Sandia CorporationInventors: Edward V. Thomas, Mark R. Robinson, David M. Haaland, Mary K. Alam
-
Patent number: 5494032Abstract: With the crude instrumentation now in use to continuously monitor the status of the fetus at delivery, the obstetrician and labor room staff not only over-recognize the possibility of fetal distress with the resultant rise in operative deliveries, but at times do not identify fetal distress which may result in preventable fetal neurological harm. The invention, which addresses these two basic problems, comprises a method and apparatus for non-invasive determination of blood oxygen saturation in the fetus. The apparatus includes a multiple frequency light source which is coupled to an optical fiber. The output of the fiber is used to illuminate blood containing tissue of the fetus. In the preferred embodiment, the reflected light is transmitted back to the apparatus where the light intensities are simultaneously detected at multiple frequencies. The resulting spectrum is then analyzed for determination of oxygen saturation.Type: GrantFiled: May 23, 1994Date of Patent: February 27, 1996Assignee: Sandia CorporationInventors: Mark R. Robinson, David M. Haaland, Kenneth J. Ward
-
Patent number: 5435309Abstract: Methods and apparatus for determining in a biological material one or more unknown values of at least one known characteristic (e.g. the concentration of an analyte such as glucose in blood or the concentration of one or more blood gas parameters) with a model based on a set of samples with known values of the known characteristics and a multivariate algorithm using several wavelength subsets. The method includes selecting multiple wavelength subsets, from the electromagnetic spectral region appropriate for determining the known characteristic, for use by an algorithm wherein the selection of wavelength subsets improves the model's fitness of the determination for the unknown values of the known characteristic. The selection process utilizes multivariate search methods that select both predictive and synergistic wavelengths within the range of wavelengths utilized. The fitness of the wavelength subsets is determined by the fitness function F=.function.(cost, performance).Type: GrantFiled: August 10, 1993Date of Patent: July 25, 1995Inventors: Edward V. Thomas, Mark R. Robinson, David M. Haaland
-
Patent number: 5355880Abstract: Methods and apparatus for, preferably, determining noninvasively and in vivo at least two of the five blood gas parameters (i.e., pH, PCO.sub.2, [HCO.sub.3.sup.- ], PO.sub.2, and O.sub.2 sat.) in a human. The non-invasive method includes the steps of: generating light at three or more different wavelengths in the range of 500 nm to 2500 nm; irradiating blood containing tissue; measuring the intensities of the wavelengths emerging from the blood containing tissue to obtain a set of at least three spectral intensities v. wavelengths; and determining the unknown values of at least two of pH, [HCO.sub.3.sup.- ], PCO.sub.2 and a measure of oxygen concentration. The determined values are within the physiological ranges observed in blood containing tissue. The method also includes the steps of providing calibration samples, determining if the spectral intensities v. wavelengths from the tissue represents an outlier, and determining if any of the calibration samples represents an outlier.Type: GrantFiled: July 6, 1992Date of Patent: October 18, 1994Assignee: Sandia CorporationInventors: Edward V. Thomas, Mark R. Robinson, David M. Haaland, Mary K. Alam
-
Patent number: 4975581Abstract: The characteristics of a biological fluid sample having an analyte are determined from a model constructed from plural known biological fluid samples. The model is a function of the concentration of materials in the known fluid samples as a function of absorption of wideband infrared energy. The wideband infrared energy is coupled to the analyte containing sample so there is differential absorption of the infrared energy as a function of the wavelength of the wideband infrared energy incident on the analyte containing sample. The differential absorption causes intensity variations of the infrared energy incident on the analyte containing sample as a function of sample wavelength of the energy, and concentration of the unknown analyte is determined from the thus-derived intensity variations of the infrared energy as a function of wavelength from the model absorption versus wavelength function.Type: GrantFiled: June 21, 1989Date of Patent: December 4, 1990Assignee: University of New MexicoInventors: Mark R. Robinson, Kenneth J. Ward, Robert P. Eaton, David M. Haaland